B2DB — Who said what, where, and when

Snehal Naik

Vice President, Science and Regulatory, BIO

Snehal Naik is listed as Vice President, Science and Regulatory, BIO. Snehal is scheduled to speak at Advanced Therapies Week 2027 on 20 January 2027.

Compiled from published conference agendas; not yet confirmed by Snehal. Is this you? Claim this profile.

About

Snehal brings 18 years of pharmaceutical industry and biotech experience across regulatory strategy and policy, cross-functional project leadership, research, and new venture incubation, and has held roles at Pfizer, Johnson and Johnson and Spark Therapeutics. With her keen interest in influencing regulatory policy and shaping the evolving framework for cell and gene therapies, Snehal previously co-chaired the Regenerative Medicine Committee at BIO and was appointed past chair of the Regulatory Affairs Committee of the American Society of Gene & Cell Therapy, along with prior participation in the Bespoke Gene Therapy Consortium, Alliance for Regenerative Medicine, Innovative Medicines Initiative and Regenerative Medicine Forum of the National Academies of Sciences, Engineering and Medicine. Her current portfolio at BIO includes priority areas in cell and gene therapy, increasing efficiency of early drug development and Phase 1 testing in the US, and topics in preclinical developmen

Upcoming

Advanced Therapies Week 2027 19 January 2027 – 21 January 2027

Spoke alongside

People who have shared a session with Snehal at events on B2DB.